MMP1 and Hepatic fibrosis: BMSCs/MMP-1 treatment resulted in decreased collagen levels and attenuated HSCs activation in fibrotic livers, subsequently resulting in amelioration of liver injury and fibrosis, indicating BMSCs/MMP-1 as a potential antifibrotic approach for the resolution of liver fibrosis.